Charalampos K.
- Country
- Greece
- Department
- Pathological Oncology unit
Research Overview
Data & Insights
Has run more than one trial at 0 of 96 partner sites.
Specializations
Lung Cancer Research
This investigator specializes in advanced therapeutics for non-small cell lung cancer, with particular focus on maintenance therapy approaches. Their research explores innovative combination treatments using targeted therapies alongside immunotherapy agents.
- Advanced/Metastatic NSCLC Treatment
- Maintenance Therapy Development
- Immunotherapy Combinations
The investigator evaluates novel therapeutic strategies aimed at improving survival outcomes in advanced lung cancer patients.
Breast Cancer Research
The investigator focuses on developing treatments for early-stage breast cancer, particularly in hormone receptor-positive disease. Their work encompasses evaluation of novel endocrine therapies for ER-positive, HER2-negative breast cancer.
- Adjuvant Endocrine Therapy
- Hormone Receptor-Positive Disease
- Novel Therapeutic Approaches
Their research aims to advance treatment options in early-stage breast cancer through innovative endocrine-based approaches.
Therapeutic Innovation
The investigator's work encompasses targeted therapeutic development across multiple oncology domains. Their research includes evaluation of novel drug combinations and comparative assessment of treatment modalities.
- Treatment Response Assessment
- Clinical Efficacy Evaluation
- Therapeutic Optimization
Their research contributes to advancing personalized treatment approaches in oncology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.